Tiludronic acid
At a glance
- Drug Originator sanofi-aventis
- Drug Licenced by Meiji Seika Pharma
- Drug Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies
- Mechanism of Action Bone resorption factor inhibitors; Osteoclast inhibitors
- USA Patent Applicants SANOFI AVENTIS US
- USA Patents 2
- NDAs 1
- Patent Applications 1,531
Table of Contents
Disclaimer